Balaxi Pharmaceuticals P/B Ratio
BALAXI • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
0.47
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity
Current Valuation Metrics
P/B Ratio
0.47
Current Price
₹20.03
Book Value/Share
₹210.91
Exchange
NSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹232 Cr
Share Capital
₹11 Cr
Reserves & Surplus
₹221 Cr
Outstanding Shares
11,000,000
Book Value per Share
₹210.91
Valuation Signal
Signal
Undervalued
Historical Avg
0.73
Historical Range
0.13 - 1.58
Percentile
40.0%
Sector Context
Sector Average
-0.14
Sector Median
0.64
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Balaxi Pharmaceuticals
- Stock appears undervalued with PB of 0.47, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 35.6% below historical average
- Trading at premium to sector average PB of -0.14
View the current stock price of Balaxi Pharmaceuticals for more insights.
P/B Ratio Historical Trend for Balaxi Pharmaceuticals
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Balaxi Pharmaceuticals
Additional stock information and data for BALAXI
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.13 | ₹210.91 | ₹26.87 | ₹232 | Low |
| 2024 | 0.4 | ₹182.73 | ₹72.31 | ₹201 | Low |
| 2023 | 0.47 | ₹183.0 | ₹86.45 | ₹183 | Low |
| 2022 | 1.07 | ₹113.0 | ₹121.45 | ₹113 | Moderate |
| 2021 | 1.58 | ₹65.0 | ₹102.60 | ₹65 | Moderate |
Sector P/B Ratio Comparison
Comparing Balaxi Pharmaceuticals with other companies in Healthcare sector
Sector Average
-0.14
Sector Median
0.64
Lowest P/B
-11.38
Highest P/B
1.09
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -11.38 | ₹4,036 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |